Funding shortfalls put target to end TB epidemic by 2035 at riskBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5779 (Published 26 October 2016) Cite this as: BMJ 2016;355:i5779
- Sophie Cousins
Global funding for tuberculosis (TB) research and development has fallen to its lowest level since 2008, raising doubts about whether the global goal of ending the epidemic by 2035 will be possible.
The 2016 report on tuberculosis research funding trends 2005-15, published by Treatment Action Group, found that funding dropped to $620.6m (£570.9m; €570m) in 2015, down more than $50m from the previous year.1
Mike Frick, TB/HIV senior project officer at Treatment Action Group, told The BMJ that the fall in funding was a result of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial